Compound Evidence File
#EC-2026-0142
Winstrol (Stanozolol)
Filed under Oral Tablets. The bureau holds 142 laboratory returns for this compound from 53 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
53 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Apr 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Mar 2026 | 16 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Jan 2026 | 14 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 14 May 2026 | 3 Jul 2026 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Jan 2026 | 6 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Dec 2025 | 20 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Nov 2025 | 16 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Apr 2026 | 14 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Jan 2026 | 4 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Dec 2025 | 8 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Jul 2026 | 13 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 9.9 | 25 Nov 2025 | 15 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Dec 2025 | 8 Mar 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 9.7 | 9.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 | 17 Dec 2024 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 8.5 | 8.5 | 8.5 | 2 Jul 2025 | 2 Jul 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 8.5 | 8.5 | 8.5 | 16 Mar 2025 | 16 Mar 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.4 | 7.9 | 9.3 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.3 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 | 21 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.2 | 7.2 | 9.0 | 23 May 2026 | 23 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 8.2 | 8.2 | 8.2 | 2 Apr 2025 | 2 Apr 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 6 | 8.1 | 6.9 | 10.0 | 17 Dec 2024 | 25 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 2 | 8.0 | 7.6 | 8.4 | 13 Feb 2025 | 24 May 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 8.0 | 8.0 | 8.0 | 24 Apr 2025 | 24 Apr 2025 |
| Xingruida XDRCASE #VI-2026-0898 | X | 3 | 7.8 | 7.3 | 8.3 | 27 Feb 2025 | 21 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.8 | 7.8 | 7.8 | 24 Apr 2025 | 24 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 7.5 | 6.9 | 8.4 | 21 May 2026 | 21 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 3 | 7.5 | 5.9 | 9.4 | 24 Apr 2025 | 19 Jan 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 7.5 | 6.6 | 8.3 | 24 Apr 2025 | 24 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 13 | 7.4 | 3.7 | 10.0 | 6 May 2025 | 21 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 4 | 7.4 | 6.3 | 9.1 | 2 Jul 2025 | 21 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 | 11 Jun 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 | 11 Jun 2025 |
| HXNetCASE #VI-2026-0061 | X | 5 | 7.0 | 5.8 | 8.8 | 25 Apr 2025 | 24 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 6.6 | 6.4 | 6.7 | 8 Jul 2025 | 19 Jan 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 6.6 | 6.0 | 7.2 | 3 Jun 2025 | 26 Jan 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 6.3 | 5.3 | 7.4 | 6 May 2025 | 23 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 | 28 Mar 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 | 11 Jun 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 | 24 Apr 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 5.7 | 5.2 | 6.1 | 8 Jul 2025 | 19 Jan 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 5.6 | 5.6 | 5.6 | 16 Mar 2025 | 16 Mar 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 | 20 Jun 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jun 2025 | 3 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 | 28 Mar 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 3.5 | 3.5 | 3.5 | 25 Apr 2025 | 25 Apr 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 1.3 | 1.3 | 1.3 | 8 Jul 2025 | 8 Jul 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 24 Apr 2025 | 24 Apr 2025 |
Open any subject to view the batch-level evidence for Winstrol (Stanozolol) alone.